Susquehanna International Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-212,194
| Closed | -$870K | – | 14548 |
|
|
2022
Q1 | $870K | Buy |
212,194
+51,858
| +32% | +$188K | ﹤0.01% | 7488 |
|
|
2021
Q4 | $572K | Buy |
160,336
+9,858
| +7% | +$34.5K | ﹤0.01% | 8817 |
|
|
2021
Q3 | $548K | Sell |
150,478
-102,355
| -40% | -$414K | ﹤0.01% | 9140 |
|
|
2021
Q2 | $1.1M | Buy |
252,833
+63,019
| +33% | +$257K | ﹤0.01% | 7500 |
|
|
2021
Q1 | $780K | Buy |
189,814
+15,974
| +9% | +$69.2K | ﹤0.01% | 8374 |
|
|
2020
Q4 | $694K | Buy |
173,840
+40,216
| +30% | +$130K | ﹤0.01% | 7567 |
|
|
2020
Q3 | $361K | Buy |
133,624
+24,497
| +22% | +$67.8K | ﹤0.01% | 8340 |
|
|
2020
Q2 | $300K | Sell |
109,127
-57,839
| -35% | -$161K | ﹤0.01% | 8370 |
|
|
2020
Q1 | $394K | Buy |
166,966
+3,632
| +2% | +$12.4K | ﹤0.01% | 7444 |
|
|
2019
Q4 | $768K | Sell |
163,334
-116,125
| -42% | -$475K | ﹤0.01% | 6047 |
|
|
2019
Q3 | $935K | Buy |
279,459
+84,275
| +43% | +$278K | ﹤0.01% | 5824 |
|
|
2019
Q2 | $642K | Buy |
195,184
+162,338
| +494% | +$470K | ﹤0.01% | 6722 |
|
|
2019
Q1 | $100K | Sell |
32,846
-115,512
| -78% | -$374K | ﹤0.01% | 8249 |
|
|
2018
Q4 | $404K | Sell |
148,358
-391,836
| -73% | -$1.29M | ﹤0.01% | 6432 |
|
|
2018
Q3 | $1.81M | Buy |
540,194
+493,826
| +1,065% | +$1.53M | ﹤0.01% | 4159 |
|
|
2018
Q2 | $120K | Buy |
+46,368
| New | +$115K | ﹤0.01% | 8968 |
|
|
2018
Q1 | – | Sell |
-138,383
| Closed | -$311K | – | 10485 |
|
|
2017
Q4 | $275K | Buy |
+138,383
| New | +$301K | ﹤0.01% | 7738 |
|
|
2017
Q2 | – | Sell |
-692,050
| Closed | -$1.96M | – | 10064 |
|
|
2017
Q1 | $1.97M | Buy |
692,050
+578,989
| +512% | +$1.39M | ﹤0.01% | 3758 |
|
|
2016
Q4 | $263K | Buy |
113,061
+64,282
| +132% | +$122K | ﹤0.01% | 8206 |
|
|
2016
Q3 | $82K | Sell |
48,779
-203,749
| -81% | -$250K | ﹤0.01% | 8011 |
|
|
2016
Q2 | $265K | Buy |
252,528
+232,571
| +1,165% | +$225K | ﹤0.01% | 7164 |
|
|
2016
Q1 | $17K | Sell |
19,957
-80,765
| -80% | -$78.2K | ﹤0.01% | 8837 |
|
|
2015
Q4 | $122K | Buy |
100,722
+37,051
| +58% | +$51.6K | ﹤0.01% | 8785 |
|
|
2015
Q3 | $108K | Buy |
63,671
+23,734
| +59% | +$46.5K | ﹤0.01% | 9097 |
|
|
2015
Q2 | $83K | Sell |
39,937
-60,912
| -60% | -$148K | ﹤0.01% | 9739 |
|
|
2015
Q1 | $273K | Sell |
100,849
-29,775
| -23% | -$75.5K | ﹤0.01% | 8138 |
|
|
2014
Q4 | $336K | Sell |
130,624
-54,574
| -29% | -$123K | ﹤0.01% | 7939 |
|
|
2014
Q3 | $339K | Sell |
185,198
-78,234
| -30% | -$171K | ﹤0.01% | 7833 |
|
|
2014
Q2 | $703K | Buy |
263,432
+66,000
| +33% | +$199K | ﹤0.01% | 6799 |
|
|
2014
Q1 | $691K | Sell |
197,432
-163,501
| -45% | -$725K | ﹤0.01% | 6176 |
|
|
2013
Q4 | $1.62M | Buy |
360,933
+16,821
| +5% | +$68.5K | ﹤0.01% | 4652 |
|
|
2013
Q3 | $1.4M | Buy |
344,112
+220,611
| +179% | +$964K | ﹤0.01% | 4726 |
|
|
2013
Q2 | $514K | Buy |
+123,501
| New | +$477K | ﹤0.01% | 5999 |
|
Other funds holding ATRS
Susquehanna International Group's ATRS Position: Q2 2022 in Review
Susquehanna International Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 212,194 shares — an estimated $870K sold.
Susquehanna International Group first reported a position in ATRS in Q2 2013 and held it in 33 quarters. The position peaked at $1.97M in Q1 2017. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Susquehanna International Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Susquehanna International Group sold 212,194 Antares Pharma, Inc. shares in Q2 2022, an estimated $870K.
- Susquehanna International Group first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 33 quarters.
- Susquehanna International Group's Antares Pharma, Inc. position peaked at $1.97M in Q1 2017.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.